Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: A prospective study
Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: A prospective study(459 views) Di Somma C, Pivonello R, Loche S, Faggiano A, Klain M, Salvatore M, Lombardi G, Colao A
Dept. Molec./Clin. Endocrinol./O., 'Federico II' University Naples, Naples, Italy
CNR Biomorphological/Funct. Sciences, 'Federico II' University Naples, Naples, Italy
Serv. di Endocrinologia Pediatrica, Osp. Regionale per le Microcitemie, Cagliari, Italy
Dept. Molec. /Clin. Endocrinol. /O., 'Federico II' University Naples, Naples, Italy
References: Aimaretti, G., Corneli, G., Razzore, P., Bellone, S., Baffoni, C., Arvat, E., Camanni, F., Ghigo, E., Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults (1998) Journal of Clinical Endocrinology and Metabolism, 83, pp. 1615-161
Bonjour, J.P., Theintz, G., Buchs, B., Sloman, D., Rizzoli, R., Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence (1991) Journal of Clinical Endocrinology and Metabolism, 73, pp. 555-563
Boscaro, M., Barzon, L., Fallo, F., Sonino, N., Cushing's syndrome (2001) Lancet, 357, pp. 783-791
Bressot, C., Meunier, P., Chapuy, M., Lejeune, E., Edouard, C., Darby, A., Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis (1979) Metabolism of Bone Diseases and Related Research, 1, pp. 303-311
Canalis, E., Mechanisms of glucocorticoid action in bone: Implications to glucorticoid-induced osteoporosis (1996) Journal of Clinical Endocrinology and Metabolism, 81, pp. 3441-3447
Chiodini, I., Carnevale, V., Torlontano, M., Fusilli, S., Guglielmi, G., Pileri, M., Modoni, S., Scillitani, A., Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: Study in eumenorrheic patients with Cushing's syndrome (1998) Journal of Clinical Endocrinology and Metabolism, 83, pp. 1863-1867
Colao, A., Cerbone, G., Pivonello, R., Aimaretti, G., Loche, S., Di Somma, C., Faggiano, A., Lombardi, G., The growth hormone (GH) response to arginine plus GH releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency (1999) Journal of Clinical Endocrinology and Metabolism, 84, pp. 1277-1282
Colao, A., Di Somma, C., Loche, S., Di Sarno, A., Klain, M., Pivonello, R., Salvatore, M., Lombardi, G., Prolactinomas in children and adolescents: Persistent bone loss after 2 years of prolactin normalization (2000) Clinical Endocrinology, 52, pp. 319-328
Colao, A., Loche, S., Cappabianca, P., De Divitiis, E., Lombardi, G., Pituitary adenomas in children and adolescents. Clinical presentation, diagnosis and therapeutical strategies (2000) Endocrinologist, 10, pp. 314-320
Colao, A., Pivonello, R., Spiezia, S., Faggiano, A., Ferone, D., Filippella, M., Marzullo, P., Lombardi, G., Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure (1999) Journal of Clinical Endocrinology and Metabolism, 84, pp. 2664-2672
Cortet, B., Cortet, C., Blanckaert, F., D'Herbomez, M., Marchandise, X., Wemeau, J.L., Decoulx, M., Dewailly, D., Quantitative ultrasound of bone and markers of bone turnover in Cushing's syndrome (2001) Osteoporosis International, 12, pp. 117-123
De Boer, H., Blok, G.J., Van Lingen, A., Teule, G.J.J., Lips, P., Van Der Veen, E.A., The consequences of childhood-onset growth hormone deficiency for adult bone mass (1994) Journal of Bone Mineral Research, 9, pp. 1319-1326
Delany, A., Gabbitas, B., Canalis, E., Cortisol down-regulates osteoblast a1 (I) procollagen mRNA by transcriptional and post-transcriptional mechanism (1995) Journal of Cellular Biochemistry, 57, pp. 488-494
Devoe, D.J., Miller, W.L., Conte, F.A., Kaplan, S.L., Grumbach, M.M., Rosenthal, S.M., Wilson, C.B., Gitelman, S.E., Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing's disease (1997) Journal of Clinical Endocrinology and Metabolism, 82, pp. 3196-3202
Di Somma, C., Colao, A., Di Sarno, A., Klain, M., Landi, M.L., Facciolli, G., Pivonello, R., Lombardi, G., Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males (1998) Journal of Clinical Endocrinology and Metabolism, 83, pp. 807-813
Di Somma, C., Pivonello, R., Loche, S., Faggiano, A., Marzullo, P., Di Sarno, A., Klain, M., Colao, A., Severe impairment of bone mass and turnover in Cushing's disease: Comparison between adolescent and adult patients (2002) Clinical Endocrinology, 56, pp. 153-158
Glastre, C., Braillou, P., David, L., Cochat, P., Meunier, P.J., Delmas, P.D., Measurement of bone mineral content of the lumbar spine by dual x-ray absorptiometry in normal children: Correlations with growth parameters (1990) Journal of Clinical Endocrinology and Metabolism, 70, pp. 1330-1333
Godang, K., Ueland, T., Bollerslev, J., Decreased bone area, bone mineral content, formative markers, and increased bone resorptive markers in endogenous Cushing's syndrome (1999) European Journal of Endocrinology, 141, pp. 126-131
Hanh, T.J., Halstead, L.R., Teitelbaum, S.L., Hanh, B.H., Altered mineral metabolism in glucocorticoid-induced osteopenia (1979) Journal of Clinical Investigation, 64, pp. 655-665
Hermus, A.R., Smals, A.G., Swinkels, L.M., Huysmans, D.A., Pieters, G.F., Sweep, C.F., Corstens, F.H., Kioppenberg, P.W., Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome (1995) Journal of Clinical Endocrinology and Metabolism, 80, pp. 2859-2865
Kane, L.A., Leinung, M.C., Scheithauer, B.W., Bergstralh, E.J., Laws, E.R., Groover, R.V., Kovacs, K., Zimmerman, D., Pituitary adenomas in childhood and adolescence (1994) Journal of Clinical Endocrinology and Metabolism, 79, pp. 1135-1140
Kaufmann, J.M., Tachman, P., Vermeulen, A., Vandeweghe, M., Bone mineral status in growth hormone deficient males with isolated and multiple pituitary deficiencies of childhood onset (1992) Journal of Clinical Endocrinology and Metabolism, 74, pp. 118-123
Khanine, V., Fournier, J.J., Requeda, E., Luton, J.P., Simon, F., Crouzet, J., Osteoporotic fractures at presentation of Cushing's disease: Two cases reports and a literature review (2000) Joint, Bone, Spine, 67, pp. 341-345
Lafferty, A.R., Chrousos, G.P., Pituitary rumors in children and adolescents (1999) Journal of Clinical Endocrinology and Metabolism, 84, pp. 4317-4323
Lebrethon, M.-C., Grossman, A.B., Afshar, F., Plowman, N.P., Besser, G.M., Savage, M.O., Linear growth and final height after treatment for Cushing's disease in childhood (2000) Journal of Clinical Endocrinology and Metabolism, 85, pp. 3262-3265
Leinung, M.C., Kane, L.A., Scheithauer, B.W., Carpenter, P.C., Laws, E.R., Zimmerman, D., Long term follow-up of transsphenoidal surgery for the treatment of Cushing's disease in children (1995) Journal of Clinical Endocrinology and Metabolism, 80, pp. 2475-2479
Leong, G.M., Mercado-Asis, L.B., Reynolds, J.C., Hill, S.C., Oldfield, E.H., Chrousos, G.P., The effect of Cushing's disease on bone mineral density, body composition, growth, and puberty: A report of an identical adolescent twin pair (1996) Journal of Clinical Endocrinology and Metabolism, 81, pp. 1905-1911
Lukert, B.P., Raisz, L.G., Glucocorticoid-induced osteoporosis: Pathogenesis and management (1990) Annals of Internal Medicine, 112, pp. 352-364
Magiakou, M.A., Mastorakos, G., Oldfield, E.H., Gomez, M.T., Doppman, J.L., Cutler, G.B., Nieman, L.K., Chrousos, G.P., Cushing's syndrome in children and adolescents (1994) New England Journal of Medicine, 331, pp. 629-636
Matkovic, V., Skeletal development and bone turnover revisited (1996) Journal of Clinical Endocrinology and Metabolism, 81, pp. 2013-2016
Manning, P., Evans, M., Reid, I., Normal bone mineral density following cure of Cushing's syndrome (1992) Clinical Endocrinology, 36, pp. 219-224
Matkovic, V., Fontana, D., Tominac, C., Goel, P., Chesnut, C.H., Factors which influence peak bone mass formation: A study of calcium balance and the inheritance of bone mass in adolescent females (1990) American Journal of Clinical Nutrition, 52, pp. 878-888
Newell-Price, J., Trainer, P., Besser, M., Grossman, A., The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states (1998) Endocrine Reviews, 19, pp. 647-672
Osella, G., Terzolo, M., Reimondo, G., Piovesan, A., Pia, A., Termine, A., Paccotti, P., Angeli, A., Serum markers of bone and collagen turnover in patients with Cushing's syndrome and in subjects with adrenal incidentalomas (1997) Journal of Clinical Endocrinology and Metabolism, 82, pp. 3303-3307
Ruegsegger, P., Medici, T., Anliker, M., Corticosteroid-induced bone loss: A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography (1983) European Journal of Clinical Pharmacology, 25, pp. 615-620
Shalet, S.M., Toogood, A., Rahim, A., Brennan, B.M.D., The diagnosis of growth hormone deficiency in children and adults (1998) Endocrine Review of, 19, pp. 203-223
Soika, L.A., Fairfield, W.P., Klibanski, A., Hormonal determinants and disorders of peak bone mass in children (2000) Journal of Clinical Endocrinology and Metabolism, 85, pp. 3951-3963
Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: A prospective study
BACKGROUND: Osteoporosis is a frequent, severe and often underestimated consequence of long-term hypercortisolism, often presenting as bone fracture. OBJECTIVE: This prospective study was designed to evaluate whether the abnormalities of bone mass and turnover can be similarly reversed in adolescent and adult patients with Cushing's disease, after correction of hypercortisolism. PATIENTS AND METHODS: Bone mineral density (BMD) at lumbar spine, serum osteocalcin (OC) and urinary cross-linked N-telopeptides of type I collagen (Ntx) levels were measured at diagnosis and 2 years after cure of Cushing's disease (CD) in six patients with childhood-onset and nine with adulthood-onset disease. Fifteen age-, sex- and body mass index (BMI)-matched healthy subjects served as controls. RESULTS: At diagnosis, BMD Z scores at lumbar spine and OC levels were lower (2-3 ± 0.1 vs. -0.2 ± 0.01; P < 0.01 and 1.6 ± 0.1 vs. 9.6 ± 1.2; P < 0.01 respectively) while urinary Ntx levels were significantly higher (139-9 ± 6.1 vs. 82.0 ± 1.6; P < 0.01) in CD patients than in controls. Among CD patients, similar values of Z scores (-2.4±0.3 vs. -2.2±0.1, P = 0.4) and OC levels (1.7 ± 0.2 vs. 1.6 ± 0-2, P = 0.6) were observed in adolescent and adults patients, whereas urinary Ntx levels were significantly higher (159.7 ± 7.9 vs. 125.9 ± 3.3, P < 0.001) in the former than in the latter group. Two years after remission from hypercortisolism, OC levels (P < 0.001) and lumbar BMD Z scores (-2.2 ± 0.3, P < 0.05; and -1.9 ± 0.2; P < 0.01, respectively) increased significantly, while urinary Ntx levels reduced significantly (P < 0.001) in both adolescent and adult patients. However, biochemical markers and Z scores of BMD remained significantly suppressed compared to controls. CONCLUSIONS: Bone impairment in childhood- and adulthood-onset Cushing's disease patients can be partly, but not completely, reversed 2 years after normalization of cortisol levels. Longer recovery times or additive therapeutic approaches are necessary to maximize peak bone mass in children and restore bone mass in adults with Cushing's disease.
Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: A prospective study
No results.
Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: A prospective study
Kim YH, Shin SW, Pellicano R, Fagoonee S, Choi IJ, Kim YI, Park B, Choi JM, Kim SG, Choi J, Park JY, Oh S, Yang HJ, Lim JH, Im JP, Kim JS, Jung HC, Ponzetto A, Figura N, Malfertheiner P, Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH, Bae SE, Choi KD, Choe J, Kim SO, Na HK, Choi JY, Ahn JY, Jung KW, Lee J, Kim DH, Chang HS, Song HJ, Lee GH, Jung HY, Seta T, Takahashi Y, Noguchi Y, Shikata S, Sakai T, Sakai K, Yamashita Y, Nakayama T, Leja M, Park JY, Murillo R, Liepniece-karele I, Isajevs S, Kikuste I, Rudzite D, Krike P, Parshutin S, Polaka I, Kirsners A, Santare D, Folkmanis V, Daugule I, Plummer M, Herrero R, Tsukamoto T, Nakagawa M, Kiriyama Y, Toyoda T, Cao X, Corral JE, Mera R, Dye CW, Morgan DR, Lee YC, Lin JT, Garcia Martin R, Matia Cubillo A, Lee SH, Park JM, Han YM, Ko WJ, Hahm KB, Leontiadis GI, Ford AC, Ichinose M, Sugano K, Jeong M, Park JM, Han YM, Park KY, Lee DH, Yoo JH, Cho JY, Hahm KB, Bang CS, Baik GH, Shin IS, Kim JB, Suk KT, Yoon JH, Kim YS, Kim DJ * Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer(297 views) N Engl J Med (ISSN: 0028-4793, 0028-4793linking, 1533-4406electronic), 2015 Jun; 30642104201566393291: 749-756. Impact Factor:59.558 ViewExport to BibTeXExport to EndNote